UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5276
Obsidian Energy
OBE
$645M
| $1.59M | ﹤0.01% |
196,061
-377,855
| -66% | -$4.24M |
2022 Q1
17 quarters
|
|
5277
Fate Therapeutics
FATE
$219M
| $1.59M | ﹤0.01% |
590,178
-1,231,537
| -68% | -$2.28M |
2017 Q2
36 quarters
|
|
5278
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$374M
| $1.59M | ﹤0.01% |
10,132
-51
| -0.5% | -$7.71K |
2014 Q4
46 quarters
|
|
5279
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$295M
| $1.59M | ﹤0.01% |
6,093
-1,485
| -20% | -$349K |
2014 Q4
46 quarters
|
|
5280
Regional Management Corp
RM
$324M
| $1.59M | ﹤0.01% |
38,484
+3,611
| +10% | +$132K |
2014 Q4
46 quarters
|
|
5281
CALL
ENI
E
$79B
| $1.58M | ﹤0.01% |
+33,800
| New | +$1.81M |
2026 Q2
0 quarters
|
|
5282
Covenant Logistics
CVLG
$801M
| $1.58M | ﹤0.01% |
35,846
-3,583
| -9% | -$131K |
2014 Q4
46 quarters
|
|
5283
Defiance Daily Target 2X Long SOFI ETF
SOFX
$53.9M
| $1.58M | ﹤0.01% |
153,467
-25,630
| -14% | -$254K |
2025 Q2
4 quarters
|
|
5284
YieldMax Gold Miners Option Income Strategy ETF
GDXY
$282M
| $1.58M | ﹤0.01% |
156,060
+10,386
| +7% | +$130K |
2026 Q1
1 quarter
|
|
5285
STRATTEC Security
STRT
$250M
| $1.58M | ﹤0.01% |
19,351
+4,333
| +29% | +$330K |
2024 Q3
7 quarters
|
|
5286
PUT
Nutrien
NTR
$33.9B
| $1.57M | ﹤0.01% |
25,000
| – | – |
2026 Q1
1 quarter
|
|
5287
Microbot Medical
MBOT
$74.6M
| $1.57M | ﹤0.01% |
806,847
-10,098
| -1% | -$20.6K |
2014 Q4
46 quarters
|
|
5288
iShares ESG Advanced Universal USD Bond ETF
EUSB
$711M
| $1.57M | ﹤0.01% |
36,187
+5,137
| +17% | +$223K |
2021 Q2
20 quarters
|
|
5289
PUT
AbCellera Biologics
ABCL
$3.85B
| $1.57M | ﹤0.01% |
+200,000
| New | +$978K |
2026 Q2
0 quarters
|
|
5290
Brainsway
BWAY
$449M
| $1.57M | ﹤0.01% |
101,077
+18,935
| +23% | +$287K |
2023 Q4
10 quarters
|
|
5291
Akebia Therapeutics
AKBA
$111M
| $1.57M | ﹤0.01% |
1,374,950
+605,479
| +79% | +$721K |
2014 Q4
46 quarters
|
|
5292
Zura Bio
ZURA
$394M
| $1.57M | ﹤0.01% |
265,314
+24,287
| +10% | +$116K |
2024 Q1
9 quarters
|
|
5293
Hamilton Insurance Group
HG
$3.64B
| $1.57M | ﹤0.01% |
46,116
-117,433
| -72% | -$3.68M |
2024 Q1
9 quarters
|
|
5294
ARK Israel Innovative Technology ETF
IZRL
$118M
| $1.56M | ﹤0.01% |
51,500
+5,053
| +11% | +$152K |
2018 Q1
33 quarters
|
|
5295
CALL
Qiagen
QGEN
$10.4B
| $1.56M | ﹤0.01% |
40,000
-8,900
| -18% | -$331K |
2024 Q4
6 quarters
|
|
5296
BTQ Technologies Corp
BTQ
$274M
| $1.56M | ﹤0.01% |
289,999
-98,215
| -25% | -$367K |
2025 Q4
2 quarters
|
|
5297
Compass Therapeutics
CMPX
$137M
| $1.56M | ﹤0.01% |
712,763
-1,678,570
| -70% | -$4.96M |
2021 Q4
18 quarters
|
|
5298
RBB Bancorp
RBB
$435M
| $1.56M | ﹤0.01% |
56,794
+44,319
| +355% | +$1.06M |
2022 Q3
15 quarters
|
|
5299
Telix Pharmaceuticals
TLX
$3.27B
| $1.55M | ﹤0.01% |
134,698
+102,398
| +317% | +$1.04M |
2024 Q4
6 quarters
|
|
5300
RiverNorth Managed Duration Municipal Income Fund II
RMMZ
$118M
| $1.55M | ﹤0.01% |
103,111
-1,228
| -1% | -$18.2K |
2022 Q1
17 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.